Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
118
118 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- PG-011GelPG-011Gel 3%Phase 31 trial
Prime Gene Therapeutics Co., Ltd. · Atopic Dermatitis
- prolgolimabBCD-100, FortecaPhase 31 trial
Biocad · Melanoma, Melanoma (Skin), Melanoma Stage III
- pz-celEB-101 Surgical application of RDEB woundsPhase 31 trial
Abeona Therapeutics, Inc · Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB
- QL2108Phase 31 trial
Qilu Pharmaceutical Co., Ltd. · Atopic Dermatitis
- TTAX01Phase 31 trial
BioTissue Holdings, Inc · Diabetic Foot Infection, Non-healing Wound, Non-healing Diabetic Foot Ulcer
- NM8074Phase 28 trials
NovelMed Therapeutics · Paroxysmal Nocturnal Hemoglobinuria, Dermatomyositis, PNH - Paroxysmal Nocturnal Hemoglobinuria
- AK139Phase 26 trials
Akeso · Asthma, Moderate-to-Severe Atopic Dermatitis, Chronic Spontaneous Urticaria
- Descartes-08Phase 24 trials
Cartesian Therapeutics · Myasthenia Gravis, Generalized, Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV)
- EVO756Phase 24 trials
Evommune, Inc. · Migraine, Chronic Inducible Urticaria, Atopic Dermatitis
- ENV-294Phase 23 trials
Enveda Therapeutics · Atopic Dermatitis (AD), Atopic Dermatitis, Asthma
- GalvokimigUCB9741Phase 23 trials
UCB · Chronic Obstructive Pulmonary Disease With Chronic Bronchitis, Atopic Dermatitis, Non-cystic Fibrosis Bronchiectasis
- GIA632Phase 23 trials
Novartis · Atopic Dermatitis, Non-segmental Vitiligo, Cutaneous Lichen Planus
- IMG-007Phase 23 trials
Inmagene LLC · Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema
- KT-621Phase 23 trials
Kymera Therapeutics, Inc. · Eosinophilic Asthma, Atopic Dermatitis, Asthma (Diagnosis)
- LT-002-158Phase 23 trials
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)
- QLS12010Phase 23 trials
Qilu Pharmaceutical Co., Ltd. · Adults With Moderate-to-severe Hidradenitis Suppurativa, Moderate-to-severe Atopic Dermatitis, Rheumatoid Arthritis (RA)
- RSS0393Phase 23 trials
Jiangsu HengRui Medicine Co., Ltd. · Psoriatic Subjects, Plaque Psoriasis in Children, Plaque Psoriasis in Adolescents
- AB-101zabalafinPhase 22 trials
Alphyn Biologics · Atopic Dermatitis (Eczema), Atopic Dermatitis Eczema, Atopic Dermatitis
- ADX-914bempikibartPhase 22 trials
Q32 Bio Inc. · Atopic Dermatitis, Alopecia Areata
- AK120JAK inhibitor users need to double the initial dosePhase 22 trials
Akeso · Atopic Dermatitis
- APG777Phase 22 trials
Apogee Therapeutics, Inc. · Atopic Dermatitis
- CadefrecitinibGLPG3667Phase 22 trials
Lakefront Biotherapeutics NV · Dermatomyositis, Systemic Lupus Erythematosus
- CamoteskimabAPL-9109Phase 22 trials
Apollo Therapeutics Ltd · Atopic Dermatitis, Atopic, Dermatitis
- CGB-500Phase 22 trials
CAGE Bio Inc. · Atopic Dermatitis (AD)
- DNA VaccinePhase 22 trials
NEC Bio B.V · Triple Negative Breast Cancer, Malignant Melanoma, Melanoma (Skin)
- FB825Phase 22 trials
Oneness Biotech Co., Ltd. · Allergic Asthma, Atopic Dermatitis
- HB0043Phase 22 trials
Shanghai Huaota Biopharmaceutical Co., Ltd. · Acne Vulgaris, Hidradenitis Suppurativa
- IfetrobanPhase 22 trials
Cumberland Pharmaceuticals · Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited
- JNJ-95597528Phase 22 trials
Johnson & Johnson (Janssen) · Dermatitis, Atopic, Asthma
- JYP0061Experimental Drug GroupPhase 22 trials
Guangzhou JOYO Pharma Co., Ltd · Moderate-to-severe Atopic Dermatitis, Neuromyelitis Optica Spectrum Disorders
- ModzatinibATI-2138Phase 22 trials
Aclaris Therapeutics, Inc. · Lichen Planus, Atopic Dermatitis
- VIS954Phase 22 trials
Otsuka · Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Inflammatory Skin Diseases
- XKH001InjectionXKH001Phase 22 trials
Zhejiang Kanova Biopharmaceutical Co., LTD · COPD, Atopic Dermatitis
- AGLE-102Phase 21 trial
Aegle Therapeutics · Dystrophic Epidermolysis Bullosa
- AT-004Phase 21 trial
Arctic Therapeutics · Acne Vulgaris on the Face
- ATB1651-102Phase 21 trial
AmtixBio Co., Ltd. · Onychomycosis
- ATI-045Phase 21 trial
Aclaris Therapeutics, Inc. · Atopic Dermatitis, Atopic, Dermatitis
- AZD6750Phase 21 trial
AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)
- B244Phase 21 trial
AOBiome LLC · Acne Vulgaris
- BI-1607Phase 21 trial
BioInvent International AB · Melanoma Metastatic, Melanoma of Skin, Melanoma BRAF V600E/K Mutated
- BimiralisibPhase 21 trial
TORQUR · Actinic Keratosis
- CPL500036Phase 21 trial
Celon Pharma SA · Parkinson Disease, Dyskinesia, Medication-Induced
- ELU42Phase 21 trial
Eluciderm Inc · Diabetic Foot Ulcer, Wagner Grade 1 - 2, Chronic Wound
- ENV-501Phase 21 trial
Hummingbird Bioscience · Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer
- EVO301Phase 21 trial
Evommune, Inc. · Atopic Dermatitis (AD), Eczema, Eczema Atopic Dermatitis
- GHZ339Phase 21 trial
Novartis · Atopic Dermatitis
- HL-300Phase 21 trial
Hangzhou Highlightll Pharmaceutical Co., Ltd · Atopic Dermatitis
- HW211026Phase 21 trial
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Actinic Keratosis
- HXN6005Phase 21 trial
Helixon Biotechnology (Suzhou) Co., Ltd · Health Adult Subjects, Atopic Dermatitis (AD)
- IBI3002Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.